NDAINJECTIONINJECTABLE
Approved
Jan 1982
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 3d ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
TECHNESCAN GLUCEPTATE is a radiopharmaceutical diagnostic agent consisting of technetium Tc-99m bound to gluceptate, a chelating compound. It is used for renal imaging and assessment of kidney function via intravenous injection. The product functions as a diagnostic tracer to visualize renal perfusion and excretion in nuclear medicine.
LOE Approaching
Product is in late-stage lifecycle with low linked job openings, suggesting limited team expansion and focus on managed decline.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on TECHNESCAN GLUCEPTATE offers limited career growth due to zero linked job openings and approaching loss of exclusivity. This is a maintenance-focused role suited for professionals managing legacy diagnostic products or optimizing operational efficiency in a declining franchise.
Product ManagerRegulatory Affairs Specialist
Worked on TECHNESCAN GLUCEPTATE at Jubilant Therapeutics? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.